CN105193499B - A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device - Google Patents
A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device Download PDFInfo
- Publication number
- CN105193499B CN105193499B CN201510697111.7A CN201510697111A CN105193499B CN 105193499 B CN105193499 B CN 105193499B CN 201510697111 A CN201510697111 A CN 201510697111A CN 105193499 B CN105193499 B CN 105193499B
- Authority
- CN
- China
- Prior art keywords
- conductive fiber
- electric
- juice
- hemostatic device
- coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 40
- 238000005345 coagulation Methods 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 239000000835 fiber Substances 0.000 claims abstract description 59
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 50
- 229940079593 drug Drugs 0.000 claims description 33
- 241001116389 Aloe Species 0.000 claims description 10
- 241001163113 Photinia glabra Species 0.000 claims description 10
- 244000261559 Smilax china Species 0.000 claims description 10
- 235000000485 Smilax china Nutrition 0.000 claims description 10
- 235000011399 aloe vera Nutrition 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 235000013871 bee wax Nutrition 0.000 claims description 9
- 239000012166 beeswax Substances 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 241000718543 Ormosia krugii Species 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 239000002657 fibrous material Substances 0.000 claims description 4
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 3
- 239000004917 carbon fiber Substances 0.000 claims description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 3
- 241001655769 Androsace Species 0.000 claims description 2
- 238000007747 plating Methods 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 abstract description 11
- 238000010438 heat treatment Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 230000015271 coagulation Effects 0.000 abstract description 5
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000003044 adaptive effect Effects 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 29
- 208000027418 Wounds and injury Diseases 0.000 description 29
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 229940030225 antihemorrhagics Drugs 0.000 description 5
- 230000000025 haemostatic effect Effects 0.000 description 5
- 239000002874 hemostatic agent Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229920000914 Metallic fiber Polymers 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 101100165177 Caenorhabditis elegans bath-15 gene Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000009297 electrocoagulation Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides a kind of electric-coagulation hemostatic device and for the Chinese medicine composition of the device, on the basis of prior art electric-coagulation hemostatic device is using electrode clamping part as heating element, addition is wound in the conductive fiber of bulk, it is in direct contact wound site with it, on the one hand active area is expanded, simultaneously because conductive fiber aggregate has, elasticity, shape are variable, therefore can be used for variously-shaped wound site, realize fast and effectively electric coagulation hemostasis.On this basis, to avoid the plasma caused by conductive fiber aggregate impedance is uniform from largely dissipating, the using effect of device entirety has been obviously improved by the adaptive improvement of other multi-angles.Cost of the present invention is relatively low, is easily achieved, and has promotion prospect outstanding.
Description
Technical field
The present invention relates to surgical medical technical fields, further to the hemostatic technique in operation, and in particular to Yi Zhong electricity
Solidifying hemostasis device and the Chinese medicine composition for the device.
Background technology
In medical treatment and nursing technology, for body surface bleeding mostly with the direct docile of the clean article such as bandage, swab stick, taut
Tightly at wound, to inhibit wound Continuous hemorrhage, on this basis, it is aided with and promotes blood, tissue fluid rapid condensation at wound
External used medicine can also further function as anastalsis.However for occurring in subcutaneous tissue bleeding, especially surgical operation
In the bleeding of internal internal organs, can not implement to stop blooding by the above method, in this case, if amount of bleeding is larger, speed compared with
Soon, then danger is easily caused due to lacking quickly and effectively hemostasis means, causes danger even if amount of bleeding is unlikely, is also easy
The surgical procedure in the clear visual field of the needs such as endoscopy surgery is impacted.
In the prior art, electric-coagulation hemostatic device is a kind of quick-acting haemostatic powder means for internal internal organs, tissue bleeding, so
And its performance is had been found that in practical applications there are apparent defects.The electric-coagulation hemostatic device of the prior art is also known as electric coagulation hemostasis
Pincers or electrocoagulation hemostatic pen, principle are directly to contact the electrode that front end generates heat with wound, are acted on and being stopped blooding using electric heating, therefore needed
Electronic thermo-head is wanted precisely to act on wound position (as shown in Fig. 1), if that when wound is excessive or wound shape is more complex, it is existing
Having the electric-coagulation hemostatic device of technology, therefore effect is poor due to being difficult to cover whole wounds.In this case, only pass through increasing
Heating head area can not also solve the problems, such as, because on the one hand excessive heating head is not easy deeply in vivo, on the other hand can not also answer
The situation more complex to wound configuration, while the careless slightly scald for being also easy to cause health tissues.
In addition, the electric-coagulation hemostatic device of the prior art is only stopped blooding by stretching into the execution electrical heating of wound position, then
If the drug for promoting hemostasis can be applied while stretching into wound, it is expected to further promote haemostatic effect.In addition, existing
For being applied to the drug research of internal bleed site in technology, many achievements are had been achieved for, however are exclusively used in cooperation coagulation
The concertedness drug of hemostasis, but has not been reported, if breakthrough can be realized in this regard, it is likely that further promote device is whole
Using effect.
Invention content
The present invention is directed to the technological deficiencies for the prior art, provide a kind of electric-coagulation hemostatic device, to solve the prior art
The technical issues of internal bleeding more complex to wound structure of middle electric-coagulation hemostatic device is difficult to effectively stop blooding.
Another technical problem that the present invention solves be for the purpose of promoting effectively the contacting of heating partial and wound site,
Improve the electrical heating material of electric-coagulation hemostatic device.
Another technical problem that the present invention solves is to alleviate the plasma generated when electric-coagulation hemostatic device work to patient
Potential hazard.
The another technical problem that the present invention solves is to promote the bondage fastness of electrode and conductive fiber.
The another technical problem that the present invention solves be to provide it is a kind of be exclusively used in above-mentioned electric-coagulation hemostatic device, promote hemostasis make
Chinese medicine composition, to the haemostatic effect of further lifting device.
The another technical problem that the present invention solves is that its hemostasis effect is further promoted on the basis of the above Chinese medicine composition
Fruit.
To realize that the above technical purpose, the present invention use following technical scheme：
A kind of electric-coagulation hemostatic device, including it is inserted into handle, pipe, electrode, conductive fiber aggregate are embedded, wherein being inserted into handle has
Tubular housing, embedded pipe are embedded in the tubular housing, and electrode one end is connected to embedded pipe lower part, and conductive fiber aggregate is
The dough being wound by conductive fiber, the bondage of conductive fiber aggregate have sky on the electrode in the embedded pipe
Between mutually isolated absorbing cavity and loading chamber, absorbing cavity lower end extends at the conductive fiber aggregate, is inserted into handle lower side
There is drug row mouth, loading chamber to be connected to by the drug row mouth with handle outside is inserted on wall.
Preferably, the conductive fiber material is metallic fiber.
Preferably, the conductive fiber material is carbon fiber.
Preferably, the endless all standing conductive fiber surfaces of the conductive coating of the conductive fiber surfaces.
Preferably, it is uniformly distributed there are three the electrodes, along embedded pipe lower circumference.
A kind of Chinese medicine composition of the electric-coagulation hemostatic device characterized for any of the above-described technical solution, including it is following heavy
Measure the ingredient of part：2~3 parts of Chinese photinia leaf juice, 1~2 part of tabasheer, 1~2 part of Smilax china L juice, 0.5~1 part of aloe leaf juice, beeswax
0.5~1 part, 0.2~0.5 part of ginseng juice, 0.5~0.8 part of pharmagel, 10 parts of water.
It is preferred on the basis of above-mentioned Chinese medicine composition, further include 0.1~0.2 part of Canton love-pea vine juice；Further preferably
, further include 0.1~0.2 part of throat grass juice factor；It is further preferred that the Chinese medicine composition by following parts by weight at grouping
At：2.5 parts of Chinese photinia leaf juice, 1.5 parts of tabasheer, 1.5 parts of Smilax china L juice, 0.6 part of aloe leaf juice, 0.6 part of beeswax, ginseng juice 0.4
Part, 0.15 part of Canton love-pea vine juice, 0.15 part of throat grass juice factor, 0.7 part of pharmagel, 10 parts of water.
In above technical scheme：
On the basis of prior art electric-coagulation hemostatic device is using electrode clamping part as heating element, addition is wound in bulk
Conductive fiber, wound site is in direct contact with it, on the one hand expands active area, simultaneously because the conductive fiber aggregate
It is variable with elasticity, shape, therefore it can be used for variously-shaped wound site, realize fast and effectively electric coagulation hemostasis.
On this basis, to avoid the plasma caused by conductive fiber aggregate impedance is uniform from largely dissipating, one
Aspect setting is located at the absorbing cavity in embedded pipe, and blood is piled up in avoid blood and leads at constant absorption wound when the device is operated
The homogenization of impedance is caused at electric fiber assembly；On the other hand, in processing link early period of conductive fiber, ensure conductive coating
Conductive fiber surfaces (as shown in Fig. 3) not exclusively are covered in, the homogenization of impedance can also be effectively relieved, and then alleviate plasma
A large amount of divergings of body.Above-mentioned guarantee conductive coating is not exclusively covered in conductive fiber surfaces, can be by various well known electricity
What coating technology was realized, such as can be influenced to electroplate liquid punching such as high pressure gas using microbubble during executing plating
The homogeneity of coating, to obtain the effect of the endless all standing of coating (as shown in attached drawing 5,6).
In addition, technical solution of the present invention is also provided with the loading chamber for conveying drug in embedded pipe, the cavity with it is upper
It states absorbing cavity spatially to keep being isolated, the position relationship of the two can be that absorbing cavity is located at embedded pipe axial location, loading chamber
In absorbing cavity periphery, to ensure that blood, loading chamber that absorbing cavity is easy to absorb at conductive fiber aggregate are easy and the external world
Connection conveying drug.
A kind of Chinese medicine composition being exclusively used in above-mentioned electric-coagulation hemostatic device provided by the invention is exactly to pass through above-mentioned loading chamber
Be delivered to wound position, on the one hand using the drug directly act on wound promote hemostasis, simultaneously because drug there are energy
Scald phenomenon in enough wound peripheries alleviated caused by excessively heating.It is arranged by absorbing cavity after being delivered to wound in order to avoid drug
It removes, the present invention is added to a certain amount of gelatin to promote its viscosity in Traditional Chinese medicine composition formula, also promotes simultaneously
The binding strength of drug and wound.
In terms of the selection of Chinese medicine composition active ingredient, excellent anthemorrhagic performance is on the one hand required, while also wanting
Ask with good thermal stability, in view of this consideration the present invention be determined through experimentation Chinese photinia, tabasheer, Smilax china L, aloe,
The ingredients such as beeswax, ginseng, prescription and electric-coagulation hemostatic device with the use of anthemorrhagic performance protrusion, while be easily obtained and cost compared with
It is low, and the addition of Canton love-pea vine and umbellate rockjasmine herb or fruit contributes to the haemostatic effect of further lifting device entirety.In addition, in the above technical side
In case, Chinese photinia leaf juice, Smilax china L juice, aloe leaf juice, ginseng juice, Canton love-pea vine juice, throat grass juice factor can be the juice of fresh drug
(such as being obtained by pressing method) can also be the concentrate that other known extracting methods obtain；And tabasheer and beeswax are
Refer to its powder.
Technical solution of the present invention cleverly introduces conductive fiber as heating device, while changing by other conformabilities
Into the using effect for effectively improving device entirety, while cost of the present invention is relatively low, is easily achieved, before having popularization outstanding
Scape.
Description of the drawings
Fig. 1 is the electric coagulation hemostasis wrench structure schematic diagram of the prior art of the present invention；
Fig. 2 is that the electric-coagulation hemostatic device of the embodiment of the present invention is executing device solid knot when stopping blooding for big wound
Structure schematic diagram；
Fig. 3 is the partial enlarged view at A in Fig. 2；
Fig. 4 is the electric-coagulation hemostatic device of the embodiment of the present invention for larger, to execute compared with gash device when stopping blooding vertical
Cross-sectional view；
Fig. 5 is the conductive fiber aggregate used in electric-coagulation hemostatic device of the present invention, the electroplating operations in preparation process
Pattern diagram；
Fig. 6 is the partial enlarged view at B in Fig. 5；
In figure：
1, handle 2, embedded pipe 3, electrode 4, conductive fiber aggregate are inserted into
5, the larger surface of a wound 6, absorbing cavity 7, loading chamber 8, blood vessel
9, blood outlet 10, conductive fiber 11, conductive coating 12, high pressure gas
13, pressure line 14, electroplating bath 15, electroplate liquid 16, gas distributor
17, microbubble 18, cathode wire 19, positive wire 20, electrode
21, drug row mouth 22, the smaller surface of a wound
Specific implementation mode
The specific implementation mode of the present invention will be described in detail below.In order to avoid excessive unnecessary details,
It will not be described in detail in following embodiment to belonging to well known structure or function.
Approximating language used in following embodiment can be used for quantitative expression, show in the feelings for not changing basic function
Quantity is allowed to have certain variation under condition.Therefore, it is not limited to this accurately with the modified numerical value of the language such as " about ", " left and right " institute
Numerical value itself.In some embodiments, the range for allowing its modified numerical value in positive and negative 10 (10%) " about " is indicated
Interior variation, for example, what " about 100 " indicated can be any numerical value between 90 to 110.In addition, " the about first numerical value arrives
In the statement of second value ", the first and second numerical value two values are at about corrected.In some cases, approximating language
It may be related with the precision of measuring instrument.
In the description of the present invention, it should be noted that unless otherwise clearly defined and limited, term " installation ", " phase
Even ", " connection " shall be understood in a broad sense, for example, it may be being fixedly connected, may be a detachable connection, or integrated connection；It can
Can also be electrical connection to be mechanical connection；It can be directly connected, can also indirectly connected through an intermediary, it can also
It is the connection inside two elements.For a person skilled in the art, it can understand that above-mentioned term exists as the case may be
Concrete meaning in the present invention.
In addition to being defined, technical and scientific term used in following embodiment has and fields technology people of the present invention
The identical meanings that member is commonly understood by.
Embodiment 1
A kind of electric-coagulation hemostatic device, including it is inserted into handle 1, embed pipe 2, electrode 3, conductive fiber aggregate 4, wherein being inserted into handle
1 there is tubular housing, embedded pipe 2 to be embedded in the tubular housing, and 3 one end of electrode is connected to 2 lower part of embedded pipe, conductive fiber
Aggregate 4 is the dough being wound by conductive fiber 10,4 bondage of conductive fiber aggregate on the electrode 3, it is described in
With the absorbing cavity 6 and loading chamber 7 that space is mutually isolated in embedding pipe 2,6 lower end of absorbing cavity extends to the conductive fiber aggregate
At 4, being inserted on 1 lower sides of handle has drug row mouth 21, and loading chamber 7 is connected to by the drug row mouth 21 with 1 outside of handle is inserted into.
On the basis of above technical scheme：
10 material of the conductive fiber is metallic fiber.
11 endless 10 surface of all standing conductive fiber of conductive coating on 10 surface of the conductive fiber.
There are three the electrodes 3, is uniformly distributed along 2 lower circumference of embedded pipe.
In a tubular form, 6 upper end of absorbing cavity has the device for providing negative pressure, so as to lead for the absorbing cavity 6 and loading chamber 7
Blood at electric fiber assembly 4 excludes in time, and the drug row mouth 21 of loading chamber 7 and its underpart is for conveying Hemostatics drug use
Stop blooding in adapting device overall execution, the drug is any external used medicine with haemostatic effect.
Embodiment 2
A kind of electric-coagulation hemostatic device, including it is inserted into handle 1, embed pipe 2, electrode 3, conductive fiber aggregate 4, wherein being inserted into handle
1 there is tubular housing, embedded pipe 2 to be embedded in the tubular housing, and 3 one end of electrode is connected to 2 lower part of embedded pipe, conductive fiber
Aggregate 4 is the dough being wound by conductive fiber 10,4 bondage of conductive fiber aggregate on the electrode 3, it is described in
With the absorbing cavity 6 and loading chamber 7 that space is mutually isolated in embedding pipe 2,6 lower end of absorbing cavity extends to the conductive fiber aggregate
At 4, being inserted on 1 lower sides of handle has drug row mouth 21, and loading chamber 7 is connected to by the drug row mouth 21 with 1 outside of handle is inserted into.
On the basis of above technical scheme：
10 material of the conductive fiber is carbon fiber.
11 endless 10 surface of all standing conductive fiber of conductive coating on 10 surface of the conductive fiber.
The electrode 3 has two, is uniformly distributed along 2 lower circumference of embedded pipe.
Loading chamber 7 and the drug row mouth 21 of its underpart stop for conveying Hemostatics drug for adapting device overall execution
Blood, the pharmaceutical formulation are as follows：2 parts of Chinese photinia leaf juice, 2 parts of tabasheer, 1 part of Smilax china L juice, 0.5 part of aloe leaf juice, beeswax 0.5
Part, 0.5 part of ginseng juice, 0.5 part of pharmagel, 10 parts of water.
Embodiment 3
A kind of electric-coagulation hemostatic device, including it is inserted into handle 1, embed pipe 2, electrode 3, conductive fiber aggregate 4, wherein being inserted into handle
1 there is tubular housing, embedded pipe 2 to be embedded in the tubular housing, and 3 one end of electrode is connected to 2 lower part of embedded pipe, conductive fiber
Aggregate 4 is the dough being wound by conductive fiber 10,4 bondage of conductive fiber aggregate on the electrode 3, it is described in
With the absorbing cavity 6 and loading chamber 7 that space is mutually isolated in embedding pipe 2,6 lower end of absorbing cavity extends to the conductive fiber aggregate
At 4, being inserted on 1 lower sides of handle has drug row mouth 21, and loading chamber 7 is connected to by the drug row mouth 21 with 1 outside of handle is inserted into.
On the basis of above technical scheme：
10 surface of conductive fiber is completely covered in the conductive coating 11 on 10 surface of the conductive fiber.
Loading chamber 7 and the drug row mouth 21 of its underpart stop for conveying Hemostatics drug for adapting device overall execution
Blood, the pharmaceutical formulation are as follows：3 parts of Chinese photinia leaf juice, 1 part of tabasheer, 2 parts of Smilax china L juice, 1 part of aloe leaf juice, 1 part of beeswax, people
Join 0.2 part of juice, 0.8 part of pharmagel, 10 parts of water.
Embodiment 4
A kind of electric-coagulation hemostatic device, including it is inserted into handle 1, embed pipe 2, electrode 3, conductive fiber aggregate 4, wherein being inserted into handle
1 there is tubular housing, embedded pipe 2 to be embedded in the tubular housing, and 3 one end of electrode is connected to 2 lower part of embedded pipe, conductive fiber
Aggregate 4 is the dough being wound by conductive fiber 10,4 bondage of conductive fiber aggregate on the electrode 3, it is described in
With the absorbing cavity 6 and loading chamber 7 that space is mutually isolated in embedding pipe 2,6 lower end of absorbing cavity extends to the conductive fiber aggregate
At 4, being inserted on 1 lower sides of handle has drug row mouth 21, and loading chamber 7 is connected to by the drug row mouth 21 with 1 outside of handle is inserted into.
On the basis of above technical scheme：
Loading chamber 7 and the drug row mouth 21 of its underpart stop for conveying Hemostatics drug for adapting device overall execution
Blood, the pharmaceutical formulation are as follows：2.5 parts of Chinese photinia leaf juice, 1.5 parts of tabasheer, 1.5 parts of Smilax china L juice, 0.6 part of aloe leaf juice, bee
0.6 part of wax, 0.4 part of ginseng juice, 0.15 part of Canton love-pea vine juice, 0.15 part of throat grass juice factor, 0.7 part of pharmagel, 10 parts of water.
Embodiment 5
Other than drug ingedient, remaining technical characteristic is the same as embodiment 4.The present embodiment pharmaceutical formulation is as follows：Chinese photinia leaf juice
2.2 parts, 1.6 parts of tabasheer, 1.7 parts of Smilax china L juice, 0.8 part of aloe leaf juice, 0.7 part of beeswax, 0.3 part of ginseng juice, Canton love-pea vine juice
0.12 part, 0.17 part of throat grass juice factor, 0.6 part of pharmagel, 10 parts of water.
The embodiments of the present invention have been described in detail above, but content is only the preferred embodiment of the present invention,
It is not intended to limit the invention.All all any modification, equivalent and improvement etc. done in the application range of the present invention, should all
It is included within protection scope of the present invention.
Claims (8)
1. a kind of electric-coagulation hemostatic device, it is characterised in that including being inserted into handle, pipe, electrode, conductive fiber aggregate are embedded, wherein inserting
Entering handle, there is tubular housing, embedded pipe to be embedded in the tubular housing, and electrode one end is connected to embedded pipe lower part, conductive fiber
Aggregate is the dough being wound by conductive fiber, and the bondage of conductive fiber aggregate is on the electrode, the embedded pipe
In extended at the conductive fiber aggregate with the mutually isolated absorbing cavity and loading chamber in space, absorbing cavity lower end, be inserted into
There is drug row mouth, loading chamber to be connected to by the drug row mouth with handle outside is inserted into, the electric-coagulation hemostatic device on handle lower sides
It further include the Chinese medicine composition of following parts by weight：2~3 parts of Chinese photinia leaf juice, 1~2 part of tabasheer, 1~2 part of Smilax china L juice, aloe
0.5~1 part of leaf juice, 0.5~1 part of beeswax, 0.2~0.5 part of ginseng juice, 0.5~0.8 part of pharmagel, 10 parts of water.
2. a kind of electric-coagulation hemostatic device according to claim 1, it is characterised in that the conductive fiber material is that metal is fine
Dimension.
3. a kind of electric-coagulation hemostatic device according to claim 1, it is characterised in that the conductive fiber material is carbon fiber.
4. a kind of electric-coagulation hemostatic device according to claim 1, it is characterised in that the conductive plating of the conductive fiber surfaces
The endless all standing conductive fiber surfaces of layer.
5. a kind of electric-coagulation hemostatic device according to claim 1, it is characterised in that there are three the electrodes, under embedded pipe
Portion's even circumferential distribution.
6. a kind of electric-coagulation hemostatic device according to claim 1, it is characterised in that further include 0.1~0.2 part of Canton love-pea vine
Juice.
7. a kind of electric-coagulation hemostatic device according to claim 6, it is characterised in that further include 0.1~0.2 part of umbellate rockjasmine herb or fruit
Juice.
8. a kind of electric-coagulation hemostatic device according to claim 7, it is characterised in that the Chinese medicine composition is by following weight
Part at being grouped as：2.5 parts of Chinese photinia leaf juice, 1.5 parts of tabasheer, 1.5 parts of Smilax china L juice, 0.6 part of aloe leaf juice, 0.6 part of beeswax,
0.4 part of ginseng juice, 0.15 part of Canton love-pea vine juice, 0.15 part of throat grass juice factor, 0.7 part of pharmagel, 10 parts of water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510697111.7A CN105193499B (en) | 2015-10-19 | 2015-10-19 | A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510697111.7A CN105193499B (en) | 2015-10-19 | 2015-10-19 | A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105193499A CN105193499A (en) | 2015-12-30 |
| CN105193499B true CN105193499B (en) | 2018-08-28 |
Family
ID=54941727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510697111.7A Expired - Fee Related CN105193499B (en) | 2015-10-19 | 2015-10-19 | A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105193499B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110960316B (en) * | 2019-12-19 | 2020-10-20 | 江志杰 | Rapid hemostasis device for hepatobiliary surgery |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491561A (en) * | 2015-01-16 | 2015-04-08 | 陈喆 | Medicine used for treating pneumonia and preparation method of medicine |
| CN204468264U (en) * | 2015-03-09 | 2015-07-15 | 上海市东方医院 | The bipolar coagulation forceps that band attracts |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6159207A (en) * | 1997-07-31 | 2000-12-12 | Yoon; Inbae | Protected ablation method and apparatus |
| US20070276363A1 (en) * | 1998-02-12 | 2007-11-29 | Boris E. Paton | Instrument and method for the end-to-end reconnection of intestinal tissues |
| US7033356B2 (en) * | 2002-07-02 | 2006-04-25 | Gyrus Medical, Inc. | Bipolar electrosurgical instrument for cutting desiccating and sealing tissue |
| US7169145B2 (en) * | 2003-11-21 | 2007-01-30 | Megadyne Medical Products, Inc. | Tuned return electrode with matching inductor |
| CN201073341Y (en) * | 2007-08-01 | 2008-06-18 | 同济大学 | Electric knife head used for hemostasia |
| US7877853B2 (en) * | 2007-09-20 | 2011-02-01 | Tyco Healthcare Group Lp | Method of manufacturing end effector assembly for sealing tissue |
| EP3013271B1 (en) * | 2013-06-27 | 2019-10-02 | Paul Weber | Apparatus for dissection and modification of tissues |
| CN203815577U (en) * | 2014-01-21 | 2014-09-10 | 陈霞 | Surgical hemostasis device |
| CN104305180A (en) * | 2014-10-09 | 2015-01-28 | 张璧云 | Edible and applicable ingredient |
| CN204971575U (en) * | 2015-09-23 | 2016-01-20 | 何晏清 | Electric -coagulation hemostatic device |
-
2015
- 2015-10-19 CN CN201510697111.7A patent/CN105193499B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491561A (en) * | 2015-01-16 | 2015-04-08 | 陈喆 | Medicine used for treating pneumonia and preparation method of medicine |
| CN204468264U (en) * | 2015-03-09 | 2015-07-15 | 上海市东方医院 | The bipolar coagulation forceps that band attracts |
Non-Patent Citations (1)
| Title |
|---|
| 鲜芦荟汁对血小板减少患者穿刺针眼止血效果观察;谷小燕;《全科医生技能发展》;20081231;第11卷(第8期);正文第1－2页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105193499A (en) | 2015-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105193499B (en) | A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device | |
| CN104225258A (en) | Traditional Chinese medicine composition for promoting wound healing | |
| CN202951650U (en) | Electric coagulation forcep support with autorotating cleaning device | |
| CN104435123A (en) | Medicine for treating rhinopathy | |
| CN203677242U (en) | Plasma orthopedic scalpel | |
| CN202446251U (en) | Elbow toothed bipolar coagulation forceps | |
| CN204971575U (en) | Electric -coagulation hemostatic device | |
| CN206324056U (en) | A kind of giant salamander skin mucus special collector | |
| CN105168368A (en) | Chinese herb extract for accelerating post-operation wound healing and application thereof | |
| CN220898783U (en) | Anti-adhesion electric coagulation forceps | |
| CN104799010A (en) | Feed additive for improving physique of monkey and preparation method of feed additive | |
| CN103893561B (en) | A kind of burn nursing patch | |
| CN209404938U (en) | Disposable non-stick controllable bipolar electric coagulation forceps | |
| CN206434358U (en) | A kind of minimally invasive probe of novel Chinese medicine | |
| CN204073081U (en) | A kind of scald processes medical flush coater | |
| CN103705972B (en) | A kind of antibacterial sewing needle coating process | |
| CN206822671U (en) | A kind of ready-package micro-wound bone taking device | |
| CN205339259U (en) | Medical fracture fixation treatment splint | |
| CN208243831U (en) | A kind of tack fat suction needle | |
| CN205514713U (en) | Burn grinds scab ware | |
| CN202920342U (en) | Bipolar electric coagulation forceps | |
| CN204170150U (en) | A kind of nano-cellulose dressing for the treatment of large-area burns | |
| CN201831956U (en) | Anti-sticking probe for microwave treatment of nasal hemorrhage | |
| CN107158079A (en) | A kind of veterinary drug for preventing and treating swine fever | |
| CN202920339U (en) | Electrocoagulation tweezer with attracting function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180828 Termination date: 20191019 |